NCT06810596 Comparing Efficacy Between Two Protocols of Intravenous Insulin Infusion for Diabetic Adults in ICU
| NCT ID | NCT06810596 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Suez Canal University |
| Condition | Glycemic Control |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-12-15 |
| Primary Completion | 2025-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-12-15 with a primary completion date of 2025-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of clinical trial is to improve the adequacy of blood sugar control in diabetic critically ill adult patients who admitted to the intensive care unit(ICU) in Suez Canal University (SCU) hospitals by comparing glycemic control efficacy between the NHS in the UK and suggested SCU Protocols of Intravenous Insulin Infusion. The main questions it aims to answer are: Is SCU protocol of Intravenous Insulin Infusion more effective than NHS protocol in achieving blood glucose control targets in critically ill adult patients? Researchers will compare glycemic control efficacy between the NHS in UK and suggested SCU Protocols of Intravenous Insulin Infusion for critically ill Adults in ICU to determine the best protocol in achieving good blood glucose control in diabetic critically ill adult patients in SCU Hospitals.
Eligibility Criteria
Inclusion Criteria: * Patients who admitted to the hospital with a potentially life-threatening condition (Critically ill patients) with HbA1C \>6.0. Exclusion Criteria: * DKA patients. * Pregnant or breast-feeding patients. * Hyperosmolar Non-Ketotic Coma.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06810596 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Glycemic Control. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06810596 currently recruiting?
Yes, NCT06810596 is actively recruiting participants. Contact the research team at Aimantouny@med.suez.edu.eg for enrollment information.
Where is the NCT06810596 trial being conducted?
This trial is being conducted at Ismailia, Egypt.
Who is sponsoring the NCT06810596 clinical trial?
NCT06810596 is sponsored by Suez Canal University. The trial plans to enroll 100 participants.